Kaplan-Meier analysis of the OS and DFS in patients with AML with different FLT3 mutations.

Comparison of (A) OS and (B) DFS in all patients with FLT3-ITD mutations, TKD mutations, both types of mutations (ITD+ and TKD mut.) and those with wt-FLT3. (C) OS and (D) DFS in patients younger than 60 with de novo AML and intermediate-risk cytogenetics.